Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018)

Historic Liabilities from Discontinued Operations for Ironwood Pharmaceuticals (IRWD) over the last 2 years, with Q4 2018 value amounting to $15.7 million.

  • Ironwood Pharmaceuticals' Liabilities from Discontinued Operations changed N/A to $15.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $15.7 million, marking a year-over-year change of. This contributed to the annual value of $15.7 million for FY2018, which is N/A changed from last year.
  • As of Q4 2018, Ironwood Pharmaceuticals' Liabilities from Discontinued Operations stood at $15.7 million.
  • Ironwood Pharmaceuticals' 5-year Liabilities from Discontinued Operations high stood at $15.7 million for Q4 2018, and its period low was $15.7 million during Q4 2018.